Remedi Selected as a ‘2026 Global Sustainable Brands 100’

Remedi has been selected for the “2026 Global Sustainable Leaders, Companies, and Brands 100” by the UN SDGs Association, and recognized as one of the Top 50 Global Sustainable Brands recommended to consumers. This recognition is based on 43 criteria, including ESG, innovation, and sustainability, highlighting Remedi’s contribution to sustainable healthcare.

Seqye Ilbo | 2026.04.13

AI Healthcare Partnership with Hippocrates Labs

Remedi has signed an MOU with Hippocrates Labs to introduce an AI-based clinical summarization system for next-generation healthcare. By integrating AI into its EMR system, Remedi aims to reduce clinicians’ workload and improve data management efficiency, while leveraging blockchain-based security for use in underserved regions.

Dailymedi | 2025.12.19

Selected for NASA Project, Demonstrating Mini X-ray Technology

Remedi has been selected for a space medical technology project at NASA’s Glenn Research Center, demonstrating its global competitiveness. REMEX-KA6 is lightweight, low-dose, and enables on-site diagnostics, making it suitable for both space and underserved regions. Remedi supplies its products to over 50 countries in collaboration with WHO and IAEA.

The JoongAng | 2025.09.29

KNTA Partners with Remedi for TB Screening

The Seoul Metropolitan Branch of the Korean National Tuberculosis Association has partnered with Remedi to improve TB and lung disease screening for vulnerable populations. Remedi’s X-ray systems will be deployed across screening sites, supporting data-based analysis and enhanced diagnostic accuracy.

MDTODAY | 2025.07.22

REMEDI delivers medical volunteer service in Cambodia with ultralight X-ray

REMEDI brought its 2.4kg portable X-ray (KA6) to Cambodia, enabling quick diagnosis in underserved areas. Powered by battery and low-dose radiation, KA6 supported both medical care and staff training—showcasing the impact of tech donation.

Edaily | 2025.06.23

Remedi Designated as a Global Leading Company of Korea, 2025

On June 27, REMEDI was selected for the 2025 Global Small Giant 1,000+ Project. As a leading exporter of portable X-ray devices, we aim to grow through advanced product development and global certifications.

Kangwon Ilbo | 2025.06.23

REMEDI Expands Access to Healthcare in the Philippines with Portable X-ray Systems

Remedi has brought portable X-ray devices to remote Philippine regions, improving diagnostic access. Partnering with local organizations, Remedi is launching mobile clinics and plans to add AI diagnostics and training for sustainable healthcare.

Stop TB Partnership | 2025.05.23

Remedi Showcases Innovative Radiation Technologies at ICARST 2025

Remedi’s portable X-ray device, Remex-KA6, drew significant attention from IAEA and global experts at ICARST 2025. Remedi’s lightweight X-ray delivers quality imaging with low radiation and is gaining global traction.

Edaily | 2025.04.15

REMEX Xcam6 Approved in Japan, Speeds Up Market Penetration

Remedi’s lightweight X-ray device, Remex Xcam6, received Japanese approval in just six months and is now on sale, offering high-quality imaging at one-third the radiation dose of traditional equipment.

Edaily | 2025.03.20

REMEDI sells Products to NASA, Anticipates Use in Space Exploration Equipment

Remedi, founded by Professor Irena of Ewha Womans University, has sold its self-developed portable X-ray device to NASA. Recognized for its low radiation, lightweight, and mobility, the device is expected to be used in space and specialized settings.

KwNews | 2024.10.02